Group III Phospholipases A2

A subcategory of secreted phospholipases A2 with specificity for PHOSPHATIDYLETHANOLAMINES and PHOSPHATIDYLCHOLINE. It occurs as a component of VENOMS and as a mammalian secretory phospholipase A2. The creation of this group is based upon similarities in the structural determinants of the enzymes including a long amino-terminal domain, a conserved group III-specific domain, and a long carboxyl-terminal domain.

Also Known As:

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	He, Lei: 1 article (04/2017)
2.	Huang, Yan: 1 article (04/2017)
3.	Li, Xuerong: 1 article (04/2017)
4.	Li, Ye: 1 article (04/2017)
5.	Lv, Zhiyue: 1 article (04/2017)
6.	Shang, Mei: 1 article (04/2017)
7.	Tang, Zeli: 1 article (04/2017)
8.	Wang, Caiqin: 1 article (04/2017)
9.	Wang, Xiaoyun: 1 article (04/2017)
10.	Wu, Yinjuan: 1 article (04/2017)

Related Diseases

1.	Liver Cirrhosis (Hepatic Cirrhosis) 04/01/2017 - "Although prior studies confirmed that group III secretory phospholipase A2 of Clonorchis sinensis (CsGIIIsPLA2) had stimulating effect on liver fibrosis by binding to LX-2 cells, large-scale expression of recombinant protein and its function in the progression of hepatoma are worth exploring. "
2.	Hepatocellular Carcinoma (Hepatoma) 04/01/2017 - "Although prior studies confirmed that group III secretory phospholipase A2 of Clonorchis sinensis (CsGIIIsPLA2) had stimulating effect on liver fibrosis by binding to LX-2 cells, large-scale expression of recombinant protein and its function in the progression of hepatoma are worth exploring. "

Related Drugs and Biologics

1.	Recombinant Proteins